Status:

NOT_YET_RECRUITING

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Lead Sponsor:

First Affiliated Hospital, Sun Yat-Sen University

Conditions:

Papillary Renal Cell Carcinoma

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The goal of this trial is to test whether patients with stage III papillary renal cell carcinoma (pRCC) could benefit from adjuvant therapy or not. The investigators invented a multi-classifier system...

Detailed Description

kidney cancer represented 4.2% of all new cancer cases, and its incidence has been increasing. Over 90% of kidney cancer cases are renal cell carcinoma (RCC), which includes various subtypes with dist...

Eligibility Criteria

Inclusion

  • Histological confirmation of pRCC
  • With confirmed diagnosis of stage III pRCC
  • Classified as high-risk by multi-classifier system
  • With moderate/good Eastern Cooperative Oncology Group (ECOG) health rating (PS): 0-1 score.
  • Receive radical operation for renal cancer with negative margin.
  • Receive no anti-cancer treatment before primary surgery.
  • The informed consent has been obtained from the patient.

Exclusion

  • Patients with Transcription factor enhancer 3(TFE3) or transcription factor EB (TFEB) translocation proven by cytogenetic analysis or by fluorescence in situ hybridization (FISH)
  • Previously received neoadjuvant therapy
  • With severe comorbidities, such as cardiovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, and chronic renal dysfunction.
  • With bad compliance or contraindication to enrollment.
  • Pregnant woman or lactating woman.
  • With contraindication to receive pembrolizumab, such as had a prior solid organ transplant, has a known history of human immunodeficiency virus infection.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

468 Patients enrolled

Trial Details

Trial ID

NCT06146777

Start Date

December 1 2023

End Date

December 1 2030

Last Update

November 29 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.